Please login to the form below

Not currently logged in

Alzheimer's drug treatment

This page shows the latest Alzheimer's drug treatment news and features for those working in and with pharma, biotech and healthcare.

FDA grants priority review for traditional approval of Biogen and Eisai’s Alzheimers drug

FDA grants priority review for traditional approval of Biogen and Eisai’s Alzheimer’s drug

The US Food and Drug Administration (FDA) has granted priority review for the traditional approval of Eisai and Biogen's Alzheimer’s treatment, Leqembi (lecanemab-irmb). ... Biogen’s own Alzheimer’s drug, Aduhelm (aducanumab), received a

Latest news

More from news
Approximately 1 fully matching, plus 13 partially matching documents found.

Subscribe to our email news alerts


Add my company

We’re a specialist health consultancy that supports companies, healthcare professionals and patients to work hand in hand with a common...

Latest intelligence

The importance of accelerating clinical trial diversity
Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
Digital Opinion Leaders: The Role of Influencers in Medical Communications
There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
Creating Hope Though Action – World Suicide Prevention Day
At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....